Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897429 · ClinicalTrials.gov registry record
Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 2,059
- Enrollment target
NCT00897429 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 2,059 participants.
The verdict
NCT00897429 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 2,059 participants
- Enrollment target
Study Summary
This research trial studies tissue samples from patients with stage II colon cancer treated on Cancer and Leukemia Group B (CALGB)-9581 or CALGB-90903. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid (DNA) and identify biomarkers related to cancer. It may also help doctors understand how patients respond to treatment.
Interventions
- PROCEDURE laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,059 participants |
| Start Date | 2007-07 |
| Est. Completion | 2019-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00897429
The ClinicalTrials.gov registry entry for NCT00897429 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,059 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT00897429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00897429 about?
NCT00897429 is a clinical study titled "Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581". This research trial studies tissue samples from patients with stage II colon cancer treated on Cancer and Leukemia Group B (CALGB)-9581 or CALGB-90903. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid...
What is the current status of trial NCT00897429?
This trial is currently completed. The enrollment target is 2,059 participants. The study started on 2007-07. Estimated completion is 2019-02.
What interventions are being tested in trial NCT00897429?
The interventions under investigation include: laboratory biomarker analysis (PROCEDURE).
Who is sponsoring clinical trial NCT00897429?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.